Adriamycine-Induced Cardiomyopathy

Abstract

Adriamycin is an antineoplastic agent used in a wide variety of malignancies. Its use is limited because of a cumulative, dose-dependent irreversible cardiomyopathy. We report a case of adriamycin-induced cardiomyopathy, after he had undergone chemotherapy for Hodgin lymphoma. The patient had no cardiac risk factors, and neither laboratory nor imaging findings suggested myocarditis or dilated cardiomyopathy. Echocardiographic findings and differential diagnosis led us to attribute his condition to subacute doxorubicin-induced cardiomyopathy.




J Med Cases. 2015;6(5):226-228
doi: http://dx.doi.org/10.14740/jmc2132w